TAYLOR MORRISON HOME CORP (TMHC) Fundamental Analysis & Valuation

NYSE:TMHC • US87724P1066

Current stock price

59.41 USD
-0.87 (-1.44%)
At close:
59.41 USD
0 (0%)
After Hours:

This TMHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. TMHC Profitability Analysis

1.1 Basic Checks

  • TMHC had positive earnings in the past year.
  • TMHC had a positive operating cash flow in the past year.
  • TMHC had positive earnings in each of the past 5 years.
  • In the past 5 years TMHC always reported a positive cash flow from operatings.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • TMHC's Return On Assets of 7.95% is fine compared to the rest of the industry. TMHC outperforms 80.00% of its industry peers.
  • TMHC has a Return On Equity of 12.43%. This is in the better half of the industry: TMHC outperforms 71.67% of its industry peers.
  • The Return On Invested Capital of TMHC (9.79%) is better than 71.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TMHC is in line with the industry average of 9.16%.
Industry RankSector Rank
ROA 7.95%
ROE 12.43%
ROIC 9.79%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • TMHC has a better Profit Margin (9.63%) than 83.33% of its industry peers.
  • In the last couple of years the Profit Margin of TMHC has grown nicely.
  • TMHC has a better Operating Margin (13.87%) than 85.00% of its industry peers.
  • TMHC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of TMHC (23.38%) is worse than 60.00% of its industry peers.
  • TMHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.87%
PM (TTM) 9.63%
GM 23.38%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. TMHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TMHC is creating some value.
  • Compared to 1 year ago, TMHC has less shares outstanding
  • TMHC has less shares outstanding than it did 5 years ago.
  • TMHC has a worse debt/assets ratio than last year.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • TMHC has an Altman-Z score of 3.66. This indicates that TMHC is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.66, TMHC is in line with its industry, outperforming 56.67% of the companies in the same industry.
  • The Debt to FCF ratio of TMHC is 2.95, which is a good value as it means it would take TMHC, 2.95 years of fcf income to pay off all of its debts.
  • TMHC's Debt to FCF ratio of 2.95 is fine compared to the rest of the industry. TMHC outperforms 63.33% of its industry peers.
  • TMHC has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.36, TMHC perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.95
Altman-Z 3.66
ROIC/WACC1.05
WACC9.3%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • TMHC has a Current Ratio of 6.81. This indicates that TMHC is financially healthy and has no problem in meeting its short term obligations.
  • TMHC's Current ratio of 6.81 is fine compared to the rest of the industry. TMHC outperforms 78.33% of its industry peers.
  • TMHC has a Quick Ratio of 1.03. This is a normal value and indicates that TMHC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, TMHC is in line with its industry, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.81
Quick Ratio 1.03
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. TMHC Growth Analysis

3.1 Past

  • The earnings per share for TMHC have decreased by -7.51% in the last year.
  • TMHC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.33% yearly.
  • Looking at the last year, TMHC shows a decrease in Revenue. The Revenue has decreased by -0.57% in the last year.
  • Measured over the past years, TMHC shows a small growth in Revenue. The Revenue has been growing by 5.79% on average per year.
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%

3.2 Future

  • Based on estimates for the next years, TMHC will show a decrease in Earnings Per Share. The EPS will decrease by -7.38% on average per year.
  • TMHC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.12% yearly.
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. TMHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.66, the valuation of TMHC can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 88.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.78, TMHC is valued rather cheaply.
  • TMHC is valuated reasonably with a Price/Forward Earnings ratio of 11.19.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TMHC indicates a somewhat cheap valuation: TMHC is cheaper than 68.33% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. TMHC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.66
Fwd PE 11.19
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TMHC indicates a somewhat cheap valuation: TMHC is cheaper than 75.00% of the companies listed in the same industry.
  • 85.00% of the companies in the same industry are more expensive than TMHC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.37
EV/EBITDA 6.14
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of TMHC may justify a higher PE ratio.
  • TMHC's earnings are expected to decrease with -7.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-7.38%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMHC Dividend Analysis

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TMHC Fundamentals: All Metrics, Ratios and Statistics

TAYLOR MORRISON HOME CORP

NYSE:TMHC (4/10/2026, 8:04:00 PM)

After market: 59.41 0 (0%)

59.41

-0.87 (-1.44%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11
Earnings (Next)04-22
Inst Owners101.83%
Inst Owner Change0.23%
Ins Owners0.59%
Ins Owner Change13.67%
Market Cap5.72B
Revenue(TTM)8.12B
Net Income(TTM)782.50M
Analysts78.82
Price Target78.36 (31.9%)
Short Float %5.75%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.42%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)1.13%
Min EPS beat(4)-2.85%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)2.57%
EPS beat(12)7
Avg EPS beat(12)4.91%
EPS beat(16)10
Avg EPS beat(16)6.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)1.08%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)5
Avg Revenue beat(8)0.84%
Revenue beat(12)9
Avg Revenue beat(12)3%
Revenue beat(16)12
Avg Revenue beat(16)2.4%
PT rev (1m)1.35%
PT rev (3m)3.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.02%
EPS NY rev (1m)0.47%
EPS NY rev (3m)-22.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.79%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-6.72%
Valuation
Industry RankSector Rank
PE 7.66
Fwd PE 11.19
P/S 0.7
P/FCF 7.37
P/OCF 7
P/B 0.91
P/tB 1.02
EV/EBITDA 6.14
EPS(TTM)7.76
EY13.06%
EPS(NY)5.31
Fwd EY8.94%
FCF(TTM)8.07
FCFY13.58%
OCF(TTM)8.48
OCFY14.28%
SpS84.31
BVpS65.33
TBVpS58.45
PEG (NY)N/A
PEG (5Y)0.33
Graham Number106.8
Profitability
Industry RankSector Rank
ROA 7.95%
ROE 12.43%
ROCE 12.83%
ROIC 9.79%
ROICexc 10.84%
ROICexgc 11.83%
OM 13.87%
PM (TTM) 9.63%
GM 23.38%
FCFM 9.57%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.58%
ROICexgc(5y)14.24%
ROCE(3y)14.02%
ROCE(5y)14.61%
ROICexgc growth 3Y-12.31%
ROICexgc growth 5Y15.36%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.95
Debt/EBITDA 1.96
Cap/Depr 100.47%
Cap/Sales 0.5%
Interest Coverage 250
Cash Conversion 70.07%
Profit Quality 99.29%
Current Ratio 6.81
Quick Ratio 1.03
Altman-Z 3.66
F-Score5
WACC9.3%
ROIC/WACC1.05
Cap/Depr(3y)96.24%
Cap/Depr(5y)86.45%
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.41%
Profit Quality(3y)73.15%
Profit Quality(5y)75.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
EPS Next Y-31.59%
EPS Next 2Y-7.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
Revenue Next Year-15.63%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.24%
EBIT growth 3Y-6.83%
EBIT growth 5Y20.52%
EBIT Next Year-28.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y347.18%
FCF growth 3Y-10.32%
FCF growth 5Y-6.47%
OCF growth 1Y289.07%
OCF growth 3Y-9.64%
OCF growth 5Y-6.16%

TAYLOR MORRISON HOME CORP / TMHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


Can you provide the profitability details for TAYLOR MORRISON HOME CORP?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.


Can you provide the financial health for TMHC stock?

The financial health rating of TAYLOR MORRISON HOME CORP (TMHC) is 6 / 10.